Pharma

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Genentech and our collaborator Biogen Idec disagreed over decision-making rights for certain of the next-generation anti-CD20 products under our 2003 collaboration agreement, and the disagreement was submitted to an arbitration panel, which issued a ruling in June 2009.

Today in M&A/Partnerships...keeping you current

Inno Biologics and CEVEC Sign License Agreement for Human CAP Technology
b3c newswire, 12/09/09

Federal Advisory Committees to Meet
HealthDataManagement, 12/09/09

Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR
Mylan, 12/09/09